Human coagulation Factor XI (LFB)

人凝血因子11（LFB）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHuman coagulation Factor XI (LFB)
Drug Alias NameHemoleven
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant coagulation factor
Mechanisms of ActionBlood coagulation pathway activationCoagulation factor XI stimulants
TargetsCoagulation factor XI
Therapy Area/IndicationsFactor XI Deficiency
Global Approved IndicationsFactor XI Deficiency
Approved Indications in ChinaN/A
Original Approved Country/TerritoryEU
Original Approved Date1999/07/01
Country/TerritoryEU
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesLfb Biotechnologies Sas
China Registration ClassN/A

Develop Information

Active CompaniesLfb Biotechnologies Sas
Inactive CompaniesN/A
Active IndicationsFactor XI Deficiency
Inactive IndicationsN/A

Other Information

ATC CodeB02BD
Related LinksWikipedia